secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERMO FISHER SCIENTIFIC INC. (TMO)
CIK:        0000097745
Form:       8-K
Filed at:   2025-07-23T23:59:59+00:00
Accession:  0000097745-25-000093
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Thermo Fisher Q2: rev +3% to $10.85B, GAAP EPS $4.28 (+6%), adj EPS $5.36
-------------------------------------------------------------------------

- Q2 revenue $10.85B (+3% YoY; organic 2%); GAAP diluted EPS $4.28, up 6% from $4.04.
- Adjusted EPS $5.36 (vs $5.37); GAAP op margin 16.9% (down 40bps); adj op margin 21.9% (down 40bps).
- 2025 annual guidance to be updated during today's earnings call.
- New product launches: Orbitrap Astral Zoom MS, Krios 5 Cryo-TEM, DynaDrive bioreactor bench scale.
- Post-quarter: expanded Sanofi partnership, acquiring Ridgefield, NJ sterile fill-finish site.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/97745/000009774525000093/0000097745-25-000093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/97745/000009774525000093/tmo-20250723.htm
  HTML page:      https://secwatch.observer/filing/0000097745-25-000093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer